## First-Line Treatment of Bipolar Depression **Key Point:** Lithium carbonate is the preferred first-line agent for acute bipolar depression, with the strongest evidence and lowest risk of mood destabilization (unlike SSRIs, which carry risk of mood switching). ### Why Lithium is Preferred in Bipolar Depression **High-Yield:** Lithium: - Has proven efficacy in bipolar depression (40–50% response rate) - Reduces suicide risk—critical in depression - Does NOT increase risk of switching to hypomania/mania (unlike SSRIs) - Provides maintenance mood stabilization across both poles - Recommended as first-line by NICE, APA, and Indian guidelines ### Mechanism in Depression - Enhances serotonergic and noradrenergic neurotransmission - Increases BDNF (brain-derived neurotrophic factor) - Modulates glutamate signalling - Neuroprotective and neuroplastic effects ### Comparative Efficacy in Bipolar Depression | Agent | Efficacy | Mood Switch Risk | First-Line | Notes | |-------|----------|------------------|-----------|-------| | **Lithium** | 40–50% | None | ✓ Yes | Gold standard; anti-suicidal | | **Lamotrigine** | 40–50% | None | Alternative | Slow onset; good for maintenance | | **SSRI (fluoxetine)** | 50–60% | **HIGH** | ✗ No | Risk of hypomania/mania; avoid monotherapy | | **Bupropion** | 50–60% | **MODERATE** | ✗ No | Activating; risk of mood destabilization | | **Quetiapine** | 60–70% | None | Alternative | Atypical antipsychotic; sedating | **Warning:** SSRIs and bupropion carry a significant risk of mood switching (hypomania/mania) in bipolar disorder and should NOT be used as monotherapy. They require concurrent mood stabilizer coverage. **Clinical Pearl:** In bipolar II disorder with depression, the risk of iatrogenic mood elevation with antidepressants is real. Lithium's efficacy without mood-switching risk makes it the safest and most evidence-based choice. **Mnemonic:** **LITHIUM BIPOLAR DEPRESSION** — Lowest mood-switch risk, Ideal for both poles, Therapeutic drug monitoring, Highest anti-suicide effect, Ideal maintenance, Unique neuroprotection, Mood stabilizer first. [cite:Harrison 21e Ch 470; NICE Bipolar Disorder 2014]
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.